The Emerging Role of Metabolomics in Epidemiological Studies of Atherosclerosis and Cardiovascular Disease
A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Advances in Metabolomics".
Deadline for manuscript submissions: 20 July 2024 | Viewed by 460
Special Issue Editors
Interests: cardiovascular disease; epidemiology; metabolic disease; metabolomics; epigenetics
Interests: epidemiology; eye disease; metabolomics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cardiovascular disease (CVD) affects around two-thirds of the world’s population. A better understanding of its mechanisms and risk factors is of critical importance for the prevention and management of this debilitating disorder. Recently, a plethora of omics studies have emerged. These multi-omics studies have helped uncover many potential candidate biomarkers and risk factors for CVD and related vascular disorders. Studies deeply exploring these biomarkers are urgently needed for translational medicine.
This Special Issue aims to extensively highlight current knowledge about newly identified metabolic markers for CVD and vascular disorders, including basic, clinical, epidemiologic and genetic findings. Here, vascular disorders include heart disease (myocardial infarction, angina, heart failure), stroke, and peripheral vascular disease. Multi-omics studies, including genomics, epigenomics, transcriptomics, proteomics, metabolomics, and gut microbiome studies, are particularly welcome.
Potential topics include, but are not limited to, the following:
- Metabolites involved in the pathogenesis of CVD and vascular disorders;
- Novel proteins and related pathways involved in CVD and vascular disorders;
- The identification of lifestyle behaviors and environmental factors that modify the risks of CVD and related disorders;
- Novel findings linking early life experience to the development of CVD and vascular disorders in later life
Dr. Hao Peng
Prof. Dr. Chenwei Pan
Dr. Changwei Li
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiovascular disease
- epidemiology
- metabolic disease
- metabolomics
- multi-omics
